Vanguard Personalized Indexing Management’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-926
Closed -$11.3K 1788
2024
Q2
$11.3K Buy
926
+173
+23% +$5.16K ﹤0.01% 1678
2024
Q1
$35K Sell
753
-537
-42% -$27.8K ﹤0.01% 1587
2023
Q4
$87.2K Sell
1,290
-731
-36% -$44.8K ﹤0.01% 1481
2023
Q3
$146K Buy
2,021
+64
+3% +$5.12K ﹤0.01% 1341
2023
Q2
$146K Buy
1,957
+842
+76% +$49.8K ﹤0.01% 1377
2023
Q1
$59.3K Sell
1,115
-904
-45% -$57.3K ﹤0.01% 1420
2022
Q4
$136K Sell
2,019
-799
-28% -$73.5K 0.01% 1200
2022
Q3
$352K Buy
2,818
+873
+45% +$104K 0.02% 909
2022
Q2
$185K Sell
1,945
-1,366
-41% -$167K 0.01% 1152
2022
Q1
$534K Buy
3,311
+2,414
+269% +$470K 0.03% 808
2021
Q4
$298K Buy
+897
New +$426K 0.02% 865

Other funds holding DNA